Clinical trials
Pituitary ACTH Hypersecretion trials in Canada
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
8 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2006 | 1 |
| 2011 | 1 |
| 2013 | 2 |
| 2014 | 1 |
| 2016 | 1 |
| 2018 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 7 |
| Active, not recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novartis Pharmaceuticals | 3 |
| Corcept Therapeutics | 2 |
| RECORDATI GROUP | 2 |
| Cortendo AB | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Pituitary ACTH Hypersecretion | 8 |
| ACTH Syndrome, Ectopic | 2 |
| Cushing Syndrome | 2 |
| Diabetes Mellitus, Type 2 | 2 |
| Hypertension | 2 |
| Acromegaly | 1 |
| Adrenal Cortex Neoplasms | 1 |
| Adrenocortical Carcinoma | 1 |
| Adrenocortical Hyperfunction | 1 |
| Dumping Syndrome | 1 |
Trials
Showing 1 to 8 of 8. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.